Piper Jaffray Cuts Price Target on Nxstage Medical (NXTM) Following Mixed 4Q Results

Go back to Piper Jaffray Cuts Price Target on Nxstage Medical (NXTM) Following Mixed 4Q Results

Selloff in NxStage Medical (NXTM) Seems 'Excessive'; BTIG Reaffirms at 'Buy'

February 11, 2016 9:48 AM EST

BTIG is out in defense of NxStage Medical, Inc. (NXTM) following the company's Q4, FY16 results reported on Wednesday. The firm rates NxStage at Buy with a price target of $27.

Analyst Sean Lavin noted that NxStage posted FY16 revenue of $336 million, which exceeded the company's outlook of $332 - $333 million. But, a... More

Nxstage Medical (NXTM) Reports In-Line Q4 EPS; Issues Light FY16 Revenue Outlook

February 10, 2016 8:07 AM EST

Nxstage Medical (NASDAQ: NXTM) reported Q4 EPS of ($0.04), in-line with the analyst estimate of ($0.04). Revenue for the quarter came in at $89.8 million versus the consensus estimate of $86.83 million.

GUIDANCE:

Nxstage Medical sees Q1 2016 revenue of $87-89 million, versus the consensus... More

Trading Radar for 2/10: Twitter (TWTR), Time Warner (TWX), Tesla (TSLA), Cisco (CSCO), Humana (HUM) Report

February 9, 2016 3:13 PM EST

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
7:00am EST

MBA Mortgage Index - no Street consensus

Earnings:

ACCO Brands Corporation (Nasdaq: ACCO) - consensus EPS $0.28
ARM Holdings plc (Nasdaq: ARMH) - consensus EPS $0.38
AmTrust Financial (Nasdaq: AFSI) - consensus EPS $0.67
Aramark Services (Nasdaq: ARMK) - consensus EPS $0.49
Axalta Coating Systems (Nasdaq:... More